Webinar – May 19th at 12 PM CST
Regenexx Corporate Overview
Orthopedic issues are the number one reason for doctor visits in the United States. These diseases cost $980 billion annually and make up 20% of your health plan spending. These conditions are not only one of the costliest areas but among the most rapidly growing major diagnostic categories. In spite of the prevalence of these surgical interventions, we are increasingly becoming aware that these surgeries are overused and misused leading to poor outcomes for patients and unnecessary costs for employers.
Regenexx has created a new medical specialty, Interventional Orthopedics. Using precise image-guided injections of orthobiologics Regenexx can intervene in place of up to 70% of elective orthopedic surgeries. Regenexx procedures are also up to a 70% savings compared to individual orthopedic surgeries. Interventional Orthopedics is a valued option that provides employees a new choice in care for orthopedic injuries.
Submit the form below to register for the webinar.
Jason Hellickson | Regenexx Corporate
- Understand the current state of musculoskeletal care and the costs involved.
- Distinguish between orthopedic surgery and interventional orthopedics.
- Identify the key issues a fiduciary must consider when deciding on adding an intervention to a health plan.
- Learn about the communication strategies that help create employee engagement.